{"cik":"0001781983","ticker":"APRE","name":"Aprea Therapeutics, Inc.","sic_code":null,"sic_description":null,"exchange":"Nasdaq","state_of_incorporation":null,"fiscal_year_end":null,"first_filing_date":"2026-04-27","last_filing_date":"2026-04-27","url":"/sec/cik-0001781983","insider_summary":{"total_transactions":0,"unique_insiders":0,"latest_transaction":null},"recent_filings":[],"related_endpoints":{"profile":"/sec/APRE/profile","timeline":"/sec/APRE/timeline","peers":"/sec/APRE/peers","insider_pulse":"/sec/APRE/insider-pulse","insider_summary":"/sec/APRE/insider-summary","insider_transactions":"/sec/APRE/insider-transactions","form144":"/sec/APRE/form144","holdings_as_filer":"/sec/APRE/holdings","financial_facts":"/sec/APRE/financial-facts","derivatives":"/sec/APRE/derivatives","officers":"/sec/APRE/officers","insider_network":"/sec/APRE/insider-network","risk_flags":"/sec/APRE/risk-flags","filings":"/sec/APRE/filings","cross_topic_dossier":"/api/v1/dossier?ticker=APRE"}}